NICOLE SOUDELIER: Open Payments
NPI 1629701701 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 39 payments from 13 companies in 2025. Trend: 2023 $801 · 2024 $894 · 2025 $1,396
Food & beverage: $1,096Consulting: $200Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $288 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $217 |
| Dexcom, Inc. | 1 | $165 |
| JAZZ PHARMACEUTICALS INC. | 3 | $159 |
| Novo Nordisk Inc | 1 | $125 |
| Lilly USA, LLC | 5 | $92 |
| Optinose US, Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| GENZYME CORPORATION | 2 | $60 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
Products named: NUCALA, LUMRYZ, DEXCOM G7 GSS (161), XYWAV, Ozempic, DUPIXENT, ZEPBOUND, Xhance.
Industry payments across LA — which companies pay providers there.
